Ainnocence Launches Self-Evolving, Multi-Objective AI Drug Discovery Platform

SAN DIEGO, California., June 13, 2022 /PRNewswire/ — Ainnocence, a global biotech startup on a mission to accelerate drug discovery using a fast, self-evolving AI drug design platform, launched today at the 2022 BIO International Convention (booth 4001). Founded by a versatile team of biomedical scientists and computer scientists, Ainnocence provides small- and large-molecule design…